| Abstract | Plasmapheresis (PMP) is effective in some clinical situations of myasthenia gravis (MG). To evaluate its usefulness before thymectomy in patients with moderate generalized MG with no respiratory involvement, we studied 24 patients with MG divided into 2 groups of 12. PMP was performed before thymectomy in one group. The course of disease and mean doses of drugs required were recorded over a follow-up period of 12 months. There were no significant differences between the 2 groups in clinical condition or mean dose of anticholinesterase agents before or after thymectomy. Significantly higher doses of corticosteroids were used after the third month of follow-up in the group treated with PMP. We conclude that PMP confers no benefit when applied before thymectomy in patients without severe MG. |
| Authors | V Iváñez, E Díez-Tejedor, M Lara, P Barreiro
(Affiliation: Servicio de Neurología, Hospital La Paz, Universidad Autónoma de Madrid.)
|
| Journal | Neurología (Barcelona, Spain)
(Neurologia)
1994 Aug-Sep
Vol. 9
Issue 7
Pg. 277-81
ISSN: 0213-4853 SPAIN |
| Vernacular Title | Utilidad de la plasmaféresis pretimectomía en el tratamiento de la miastenia grave. |
| PMID | 7946422
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
| Chemical References |
- Pyridostigmine Bromide
- Azathioprine
- Prednisone
|
| Topics |
- Adolescent
- Adult
- Aged
- Azathioprine
(administration & dosage, therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Myasthenia Gravis
(surgery, therapy)
- Plasmapheresis
- Prednisone
(administration & dosage, therapeutic use)
- Pyridostigmine Bromide
(administration & dosage, therapeutic use)
- Thymectomy
- Thymus Gland
(surgery)
- Treatment Outcome
|
